HOME › DRUGS › BAZEDOXIFENE
ACTIVE SUBSTANCE / INN

BAZEDOXIFENE

Brand name(s): Conbriza, Brilence
EMA LISTED
APPLICATION WITHDRAWN
AUTHORISED
Osteoporosis, Postmenopausal
ACTIVE SUBSTANCE
Bazedoxifene
REGULATORS
EMA
SPONSORS / MAH
Pfizer Europe MA EEIG, Wyeth Europa Ltd
TOTAL APPLICATIONS
2
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
ConbrizaPfizer Europe MA EEIGAuthorised17/04/2009Osteoporosis, Postmenopausal
BrilenceWyeth Europa LtdApplication withdrawn—

FULL INTELLIGENCE ON BAZEDOXIFENE

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →